The role of the complement system in resistance to experimental candida albicans infection in mice
Morelli, R.; Rosenberg, L.T.
Federation Proceedings 30(2): 356
1971
ISSN/ISBN: 0014-9446
Accession: 027722801
PDF emailed within 1 workday: $29.90
Related References
Han, Y.; Han, S.; Cutler, J.E. 2000: Does complement play a role in antibody protection against experimental vaginal infection due to Candida albicans? Abstracts of the General Meeting of the American Society for Microbiology 100: 329Lagrange, P.H.; Fourgeaud, M.; Neway, T.; Pilet, C. 1994: Enhanced resistance against lethal disseminated Candida albicans infection in mice treated with polar glycopeptidolipids from Mycobacterium chelonae (pGPL-Mc) - Augmentation de la résistance des souris traitées par des glycopeptidolipides polaires de Mycobacterium chelonae (GPLp-Mc) vis-à-vis de l'infection létale induite par Candida albicans Comptes Rendus de l'Academie des Sciences. Serie 3, Sciences de la Vie 317(12): 1107-1113
Mikami, Y.; Tabeta, H.; Arai, T. 1983: Role of active immunization in the resistance to Candida albicans infection in mice Japanese Journal of Medical Mycology 24(3): 165-171
Basu, S.; Quilici, C.; Zhang, H-Hua.; Grail, D.; Dunn, A.R. 2008: Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans Growth Factors 26(1): 23-34
Morelli, R.; Rosenberg, L.T. 1971: Role of complement during experimental Candida infection in mice Infection and Immunity 3(4): 521-523
Okawa, Y.; Kobayashi, M.; Sakai, K.; Suzuki, M. 2004: Role of polymorphonuclear leukocytes in the resistance of tumor-bearing mice against Candida albicans infection Biological and Pharmaceutical Bulletin 27(5): 674-678
Bistoni, F.; Baccarini, M.; Blasi, E.; Marconi, P.; Puccetti, P.; Garaci, E. 1983: Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice Infection and Immunity 40(1): 46-55
Nadeev, A.P.; Shkurupii, V.A.; Pozdnyakova, S.V.; Travin, M.A. 2006: Mononuclear phagocyte system in mice with intrauterine Candida albicans infection and postnatal experimental tuberculosis Bulletin of Experimental Biology and Medicine 141(1): 95-98
Dimitrova, P.; Yordanov, M.; Danova, S.; Ivanovska, N. 2008: Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA Fems Immunology and Medical Microbiology 53(2): 231-236
Eng, R.H.K.; Person, A.; Chmel, H. 1981: The fate of candida albicans antigens in experimental candida infection in mice Clinical Research 29(2): 384A
Fulurija, A.; Ashman, R.B.; Papadimitriou, J.M. 1996: Early inflammatory responses to Candida albicans infection in inbred and complement-deficient mice Fems Immunology and Medical Microbiology 14(2-3): 83-94
Marquis, G.; Montplaisir, S.; Pelletier, M.; Auger, P.; Lapp, W.S. 1988: Genetics of resistance to infection with Candida albicans in mice British Journal of Experimental Pathology 69(5): 651-660
Huppert, M.; Cazin, J.; Smith, H. 1955: Pathogenesis of Candida albicans infection following antibiotic therapy. III. The effect of antibiotics on the incidence of Candida albicans in the intestinal tract of mice Journal of Bacteriology 70(4): 440-447
Toshioka, T.; Aizawa, K. 1976: Infection promoting effect of cefamezin on the experimental infection of candida albicans in mice Nihon University Journal of Medicine 18: 37-54
Aizawa, K.; Toshioka, T. 1976: Infection promoting effect of oleandomycin on the experimental infection of candida albicans in mice Nihon University Journal of Medicine 18(3): 195-216